내가 좋아할 만한 콘텐츠
Well done @CPDR_Labs Great representation yesterday 🎊🎉
CPDR trainees from @xiaofengsu and @AyeshaShafi_PhD labs present their research on #prostatecancer at @HJFMilMed Research Day. @USUhealthsci #nextgen
Privileged to moderate the #cancer session at HJF Research Day and introduce the @CPDR_Labs PIs, their labs, and new tech/research directions #ProstateCancer - we are coming for you 🤓😈
CPDR Scientific Director @EllisLab_ provides an overview of CPDR’s vision, highlights of the ongoing team science projects, and shoutout to the faculty part of the team at @HJFMilMed Research Day.
Great work Moray 🎉
Moray J. Campbell, PhD, MS, recipient of the 2025 Cancer Research Communications Award for Outstanding Journal Article, summarizes the implications of his study's findings in the clip below. Watch the full interview to learn more: brnw.ch/21wXzyC
Great catching up with my mentors Drs. Roberto Pili and John Isaacs and starting US life at Johns Hopkins #SBUR2025
The seed and soil discussion is an interesting concept yet to be truly answered. Great to see this work continuing #SBUR2025
Dr. Isaac Kim, Chair of Yale Urology, gave a stunning talk on how cytoreductive radical prostatectomy plus systemic therapy can yield deep and durable benefit in ~20% of patients with metastatic prostate cancer, with Dr. Su Deng chairing the session.@Yale_Urology @SuDeng_PhD
@BeatrizGerFalc showing her new spatial data to map chromatin accessible in #prostatecancer @UrologySBUR @CPDR_Labs #SBUR2025
It was wonderful to see so many new faces at our reception yesterday. Welcome to our community! We are excited to have you with us! #sbur2025
#SBUR2025 is officially underway! Learn about Innovative Models and Technologies in Urological Research and more at #SBUR2025!
The AUA Lecture was delivered by Dr. Jiaoti Huang from Duke University at #SBUR2025 on castration resistance of prostate cancer and neuroendocrine differentiation.
@EllisLab_ presents his team’s work on spatial mapping of accessible chromatic landscape in #prostatecancer at the @UrologySBUR meeting. #teamscience #chromatin #phenotypicplasticity
A new direction for the lab. Thank you @UrologySBUR for the opportunity to present this new data. Shoutout to @BeatrizGerFalc leading this work in the lab.
@EllisLab_ presents his team’s work on spatial mapping of accessible chromatic landscape in #prostatecancer at the @UrologySBUR meeting. #teamscience #chromatin #phenotypicplasticity
Very sad to hear this
Sadden to hear the passing of Dr. Bert O’Malley, the father of molecular endocrinology, a long-time mentor, and friend.
Sadden to hear the passing of Dr. Bert O’Malley, the father of molecular endocrinology, a long-time mentor, and friend.
Ten years ago, we discovered that reactivating transposable elements triggers an antiviral state in cancer cells, a process we named viral mimicry, unmasking tumors to the immune system (Roulois, Cell 2015). Now this idea finally reached patients with some impressive results:
Now online in @CD_AACR: Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell Lymphoma - by Cheng Huang, Yan Gao, Jianfeng Chen, Choon Kiat Ong, Huiqiang Huang, and Jing Tan doi.org/10.1158/2159-8…
Thrilled see our paper out in @Nature ! 🤩 Wonderful collaboration with @GoCasteloBranco. Kudos to my amazing postdoc @Di_0579 at @YaleEngineering and Leslie Kirby from Goncalo's lab @karolinskainst. Huge team science with @YaleMed @UCSF @ASTARsg nature.com/articles/s4158…
Fred Hutch Biostatistics is hiring (Asst/Assoc/Full Prof)! We seek scholars who lead with statistical thinking and connect computation, medicine & science across imaging, AI, genomics, clinical trials & cancer prevention. Apply by Dec 1, 2025: apply.interfolio.com/176402
It was a fantastic experience 🙂- learned a lot !!
Congrats to @BeatrizGerFalc for completion of @jitcancer Peer Review Mentorship Program. A great initiative to get the #nextgen #immunology researchers to the next level. @CPDR_Labs
🎉🎊
JUST IN: 2 Belzutifan (HIF2 inhibitor) phase III trials POSTIVE for Primary Endpoint in Renal Cell Carcinoma: LITEPSPAK022 (adjuvant) + LITESPARK011 (metastatic, post PD1). BIG NEWS for GU Oncology + Kidney Cancer patients! tinyurl.com/2hywykhk tinyurl.com/mwawkbz7
United States 트렌드
- 1. Texas 150K posts
- 2. #HookEm 9,477 posts
- 3. 3-8 Florida 1,642 posts
- 4. Reaves 13.5K posts
- 5. Arch Manning 6,514 posts
- 6. Jeff Sims 1,539 posts
- 7. Aggies 8,721 posts
- 8. Sark 4,520 posts
- 9. Marcel Reed 4,207 posts
- 10. #LakeShow 2,716 posts
- 11. Arizona 31.9K posts
- 12. Devin Vassell 1,996 posts
- 13. SEC Championship 4,804 posts
- 14. Elko 2,661 posts
- 15. #DonCheadleDay N/A
- 16. #iufb 3,429 posts
- 17. #OPLive 2,360 posts
- 18. Ole Miss 25.1K posts
- 19. Giannis 8,062 posts
- 20. Bears 135K posts
내가 좋아할 만한 콘텐츠
-
PCF Science
@PCF_Science -
Hsieh Lab
@HsiehLab -
Eli Van Allen
@VanAllenLab -
Elizabeth McKenna
@ElizSMcKenna -
Nima Sharifi
@NimaSharifiMD -
Josh Lang
@JoshLangMD -
Jelani Zarif Lab
@Zarif_Lab -
Salma Kaochar
@Kaochar2 -
Misha Beltran
@mishabeltran -
Karen Sfanos
@sfanoslab -
Adam Sharp
@AdamSharpMedOnc -
Christopher Sweeney, MBBS
@ChrisSweens1 -
Srinivas Viswanathan
@srviswanathan -
Ana Aparicio
@aaparicioMD -
Charles Ryan
@charlesryanmd
Something went wrong.
Something went wrong.